Cited by 8Lipid metabolism and biosynthesisFOXO transcription factor regulationMetabolism, Diabetes, and Cancer

Mammalian target of rapamycin complex 1 and FoxO1 in the transcriptional control of lipolysis and de novo lipogenesis

Open access
Kandror, Konstantin V.·2017·Current Opinion in Endocrinology, Diabetes & Obesity

Abstract

Purpose of review: Postprandial suppression of lipolysis in adipose tissue and stimulation of de novo lipogenesis (DNL) in the liver by insulin are essential for the metabolic homeostasis in the mammalian organism. The mechanism of coregulation of lipolysis and DNL is not clear. Recent findings: Insulin controls both lipolysis and DNL at the level of transcription via the same mammalian target of rapamycin complex 1 (mTORC1) and FoxO1-mediated signaling pathways. Summary: mTORC1 suppresses lipolysis in adipose tissue and activates DNL in the liver, whereas FoxO1 has the opposite effect. Individual inputs of either mTORC1 or FoxO1 in the regulation of lipid metabolism may be difficult to evaluate because of the cross talk between these pathways.

Integrity signals

Registry

Crossref · 10.1097/med.0000000000000352

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kandror, K. V.
Affiliations
Boston University (US)
Corresponding author
Kandror, Konstantin V.
Venue
Current Opinion in Endocrinology, Diabetes & Obesity
Published
2017-10
Volume
24
Issue
5
Pages
326-331
ISSN
  • 1752-296X (ISSN-L)
  • 1752-2978
OpenAlex
W2749064220
Cited by
8
References
86
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2022: 1 · 2019: 1 · 2018: 3
FWCI
0.55
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Endocrinology Diabetes and Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (R56DK052057, R01DK052057, R01DK107498)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
mTORC1, FOXO1, lipolysis, de novo lipogenesis, insulin signaling, adipose tissue, liver, transcriptional regulation, lipid metabolism, metabolic homeostasis
MeSH terms
Forkhead Box Protein O1, Mechanistic Target of Rapamycin Complex 1, Adipose Tissue, Animals, Gene Expression Regulation, Humans, Insulin, Insulin Resistance, Lipolysis, Liver, Transcription, Genetic, Signal Transduction, Lipogenesis, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review